Lexaria Biosci 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cannabidiol (DehydraTECH-CBD) / Lexaria Biosci
DehydraTECH, NCT06648031: Comparison of the Safety, Efficacy and Pharmacokinetics of -CBD and -GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

Recruiting
1
80
RoW
Arm 1 - DehydraTECH-CBD alone, Arm 2 - DehydraTECH-semaglutide alone, Arm 3 - DehydraTECH-CBD in combination with DehydraTECH-semaglutide, Arm 4 - Rybelsus medication (semaglutide) alone, Arm 5- Tirzepatide
Lexaria Bioscience Corp.
Type2diabetes
06/25
09/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cannabidiol (DehydraTECH-CBD) / Lexaria Biosci
DehydraTECH, NCT06648031: Comparison of the Safety, Efficacy and Pharmacokinetics of -CBD and -GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

Recruiting
1
80
RoW
Arm 1 - DehydraTECH-CBD alone, Arm 2 - DehydraTECH-semaglutide alone, Arm 3 - DehydraTECH-CBD in combination with DehydraTECH-semaglutide, Arm 4 - Rybelsus medication (semaglutide) alone, Arm 5- Tirzepatide
Lexaria Bioscience Corp.
Type2diabetes
06/25
09/25

Download Options